168 related articles for article (PubMed ID: 23768804)
1. Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803.
Jaklitsch MT; Gu L; Demmy T; Harpole DH; D'Amico TA; McKenna RJ; Krasna MJ; Kohman LJ; Swanson SJ; DeCamp MM; Wang X; Barry S; Sugarbaker DJ;
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):9-16. PubMed ID: 23768804
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of restaging endobronchial ultrasound in patients with non-small cell lung cancer after preoperative therapy.
Nasir BS; Bryant AS; Minnich DJ; Wei B; Dransfield MT; Cerfolio RJ
Ann Thorac Surg; 2014 Sep; 98(3):1008-12. PubMed ID: 25069682
[TBL] [Abstract][Full Text] [Related]
3. Accurate and safe mediastinal restaging by combined endobronchial and endoscopic ultrasound-guided needle aspiration performed by single ultrasound bronchoscope.
Szlubowski A; Zieliński M; Soja J; Filarecka A; Orzechowski S; Pankowski J; Obrochta A; Jakubiak M; Węgrzyn J; Cmiel A
Eur J Cardiothorac Surg; 2014 Aug; 46(2):262-6. PubMed ID: 24420366
[TBL] [Abstract][Full Text] [Related]
4. Endobronchial ultrasound-guided needle aspiration in non-small-cell lung cancer restaging verified by the transcervical bilateral extended mediastinal lymphadenectomy--a prospective study.
Szlubowski A; Herth FJ; Soja J; Kołodziej M; Figura J; Cmiel A; Obrochta A; Pankowski J
Eur J Cardiothorac Surg; 2010 May; 37(5):1180-4. PubMed ID: 20022759
[TBL] [Abstract][Full Text] [Related]
5. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
[TBL] [Abstract][Full Text] [Related]
6. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
Cerfolio RJ; Bryant AS; Ojha B
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
8. The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Eloubeidi MA; Frederick PA; Minnich DJ; Harbour KC; Dransfield MT
Ann Thorac Surg; 2010 Aug; 90(2):427-34. PubMed ID: 20667324
[TBL] [Abstract][Full Text] [Related]
9. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
10. Mediastinoscopy, thoracoscopy and left anterior mediastinotomy in the diagnosis of N2 non small cell lung cancer.
Carbognani P; Rusca M; Spaggiari L; Cattelani L; Bobbio A; Romani A; Solli P
J Cardiovasc Surg (Torino); 1996 Dec; 37(6 Suppl 1):177-8. PubMed ID: 10064372
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of multi-level N2-positive non-small cell lung cancer according to lymph node staging using endobronchial ultrasound-transbronchial biopsy.
Yoon HY; Lee JC; Kim SW; Kim HR; Kim YH; Choi SH; Kim SS; Song SY; Choi EK; Jang SJ; Choi CM
Thorac Cancer; 2018 Jun; 9(6):684-692. PubMed ID: 29607613
[TBL] [Abstract][Full Text] [Related]
12. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
Kremer R; Peysakhovich Y; Dan LF; Guralnik L; Kagna O; Nir RR; Bar-Shalom R
Ann Nucl Med; 2016 Feb; 30(2):114-21. PubMed ID: 26613715
[TBL] [Abstract][Full Text] [Related]
14. Transcervical extended mediastinal lymphadenectomy: results of staging in two hundred fifty-six patients with non-small cell lung cancer.
Zieliński M
J Thorac Oncol; 2007 Apr; 2(4):370-2. PubMed ID: 17409815
[TBL] [Abstract][Full Text] [Related]
15. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
16. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway.
Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109
[TBL] [Abstract][Full Text] [Related]
17. Remediastinoscopy in restaging of lung cancer after induction therapy.
Marra A; Hillejan L; Fechner S; Stamatis G
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):843-9. PubMed ID: 18374765
[TBL] [Abstract][Full Text] [Related]
18. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
19. Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer.
Herth FJ; Annema JT; Eberhardt R; Yasufuku K; Ernst A; Krasnik M; Rintoul RC
J Clin Oncol; 2008 Jul; 26(20):3346-50. PubMed ID: 18519953
[TBL] [Abstract][Full Text] [Related]
20. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
Cerfolio RJ; Bryant AS; Eloubeidi MA
Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
